Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Points to Consider: Best Practices to Identify Particle Entry Routes along the Manufacturing Process for Parenteral Formulations.
Journal: PDA journal of pharmaceutical science and technology
Published: August 18, 2019
Achieving "Zero" Defects for Visible Particles in Injectables.
Journal: PDA journal of pharmaceutical science and technology
Published: September 21, 2018
IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors.
Journal: Cancer letters
Published: October 10, 2012
Showing 1-3 of 3
Last Updated: 09/26/2026